These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 37917181

  • 61. Direct Visualization of Drug-Polymer Phase Separation in Ritonavir-Copovidone Amorphous Solid Dispersions Using in situ Synchrotron X-ray Fluorescence Imaging of Thin Films.
    Shi C, Li L, Zhang GGZ, Borchardt TB.
    Mol Pharm; 2019 Nov 04; 16(11):4751-4754. PubMed ID: 31553871
    [Abstract] [Full Text] [Related]

  • 62. Solubility Advantage (and Disadvantage) of Pharmaceutical Amorphous Solid Dispersions.
    Huang S, Mao C, Williams RO, Yang CY.
    J Pharm Sci; 2016 Dec 04; 105(12):3549-3561. PubMed ID: 27692620
    [Abstract] [Full Text] [Related]

  • 63. The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone.
    Xi H, Ren J, Novak JM, Kemp E, Johnson G, Klinzing G, Johnson MA, Xu W.
    Pharm Res; 2020 Mar 16; 37(4):70. PubMed ID: 32185516
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. Interplay of Drug-Polymer Interactions and Release Performance for HPMCAS-Based Amorphous Solid Dispersions.
    Bapat P, Paul S, Tseng YC, Taylor LS.
    Mol Pharm; 2024 Mar 04; 21(3):1466-1478. PubMed ID: 38346390
    [Abstract] [Full Text] [Related]

  • 66. Molecular dynamics simulation of amorphous indomethacin-poly(vinylpyrrolidone) glasses: solubility and hydrogen bonding interactions.
    Xiang TX, Anderson BD.
    J Pharm Sci; 2013 Mar 04; 102(3):876-91. PubMed ID: 23280486
    [Abstract] [Full Text] [Related]

  • 67. Evolution of supersaturation from amorphous solid dispersions in water-insoluble polymer carriers: Effects of swelling capacity and interplay between partition and diffusion.
    Schver GCRM, Nadvorny D, Lee PI.
    Int J Pharm; 2020 May 15; 581():119292. PubMed ID: 32243967
    [Abstract] [Full Text] [Related]

  • 68. Micro-Injection Moulding of Poly(vinylpyrrolidone-vinyl acetate) Binary and Ternary Amorphous Solid Dispersions.
    Pezzoli R, Hopkins Jnr M, Direur G, Gately N, Lyons JG, Higginbotham CL.
    Pharmaceutics; 2019 May 18; 11(5):. PubMed ID: 31109108
    [Abstract] [Full Text] [Related]

  • 69. Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.
    Correa Soto CE, Gao Y, Indulkar AS, Ueda K, Zhang GGZ, Taylor LS.
    Pharm Res; 2022 Jan 18; 39(1):167-188. PubMed ID: 35013849
    [Abstract] [Full Text] [Related]

  • 70. Insight into Amorphous Solid Dispersion Performance by Coupled Dissolution and Membrane Mass Transfer Measurements.
    Hate SS, Reutzel-Edens SM, Taylor LS.
    Mol Pharm; 2019 Jan 07; 16(1):448-461. PubMed ID: 30521350
    [Abstract] [Full Text] [Related]

  • 71. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR.
    Baghel S, Cathcart H, O'Reilly NJ.
    Int J Pharm; 2018 Jan 30; 536(1):414-425. PubMed ID: 29183857
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD, Pinto JF, Henriques J, Paiva AM.
    Mol Pharm; 2022 Jan 03; 19(1):51-66. PubMed ID: 34919407
    [Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75. Water-Resistant Drug-Polymer Interaction Contributes to the Formation of Nano-Species during the Dissolution of Felodipine Amorphous Solid Dispersions.
    Liu L, Chen L, Müllers W, Serno P, Qian F.
    Mol Pharm; 2022 Aug 01; 19(8):2888-2899. PubMed ID: 35759395
    [Abstract] [Full Text] [Related]

  • 76. A novel amorphous solid dispersion based on drug-polymer complexation.
    Meng F, Ferreira R, Su Y, Zhang F.
    Drug Deliv Transl Res; 2021 Oct 01; 11(5):2072-2084. PubMed ID: 33151484
    [Abstract] [Full Text] [Related]

  • 77. Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution Vessel.
    Salehi N, Al-Gousous J, Mudie DM, Amidon GL, Ziff RM, Amidon GE.
    Mol Pharm; 2020 Oct 05; 17(10):3870-3884. PubMed ID: 32886520
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Explaining the Release Mechanism of Ritonavir/PVPVA Amorphous Solid Dispersions.
    Krummnow A, Danzer A, Voges K, Dohrn S, Kyeremateng SO, Degenhardt M, Sadowski G.
    Pharmaceutics; 2022 Sep 08; 14(9):. PubMed ID: 36145652
    [Abstract] [Full Text] [Related]

  • 80. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD, Lee PI.
    Mol Pharm; 2015 Apr 06; 12(4):1203-15. PubMed ID: 25775257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.